The role of third complement component (C3) in homing of hematopoietic stem/progenitor cells into bone marrow

Advances in Experimental Medicine and Biology

Volumn 586, Issue , 2006, Pages 35-51

  Reca, Ryan ^a   Wysoczynski, Marcin ^a   Yan, Jun ^a   Lambris, John D ^b   Ratajczak, Mariusz Z ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84934438782     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/0-387-34134-X_3     Document Type: Conference Paper

References (66)

1. T. Lapidot, A. Dar, and O. Kollet. How do stem cells find their way home? Blood 2005 [Epub ahead of print].
2. T. Lapidot and O. Kollet. The essential roles of the chemokine SDF-1 and its receptor CXCR4 in human stem cell homing and repopulation of transplanted immune-deficient NOD/SCID and NOD/SCID/B2m(null) mice, Leukemia 16 (10), 1992-2003 (2002).
3. R. Horuk. Chemokine receptors, Cytokine Growth Factor Rev 12 (4), 313-335 (2001).
4. A. Aiuti, I.J. C. Webb, C. Bleul, T. Springer, and J.C. Gutierrez-Ramos. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood, J Exp Med 185 (1), 111-120 (1997).
5. R. Mohle, F. Bautz, S. Rafii, M.A. Moore, W. Brugger, and L. Kanz. The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1, Blood 91 (12), 4523-4530 (1998).
6. B. Lee, J. Ratajczak, R.W. Doms, A.M. Gewirtz, and M.Z. Ratajczak. Coreceptor/chemokine receptor expression on human hematopoietic cells: biological implications for human immunodeficiency virus-type 1 infection. Blood 93 (4), 1145-1156 (1999).
7. Y.R. Zou, A.H. Kottmann, M. Kuroda, I. Taniuchi, and D.R. Littman. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development, Nature 393 (6685), 595-599 (1998).
8. K. Tachibana, S. Hirota, H. Iizasa, H. Yoshida, K. Kawabata, Y. Kataoka, Y. Kitamura, K. Matsushima, N. Yoshida, S. Nishikawa, T. Kishimoto, and T. Nagasawa. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract, Nature 393 (6685), 591-594 (1998).
9. T. Nagasawa, S. Hirota, K. Tachibana, N. Takakura, S. Nishikawa, Y. Kitamura, N. Yoshida, H. Kikutani, and T. Kishimoto. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1, Nature 382 (6592), 635-638 (1996).
10. Q. Ma, D. Jones, P.R. Borghesani, R.A. Segal, T. Nagasawa, T. Kishimoto, R.T. Bronson, and T.A. Springer. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice, Proc Natl Acad Sci USA 95 (16), 9448-9453 (1998).
11. M.Z. Ratajczak, M. Majka, M. Kucia, J. Drukala, Z. Pietrzkowski, S. Peiper, and A. Janowska-Wieczorek. Expression of functional CXCR4 by muscle satellite cells and secretion of SDF-1 by muscle-derived fibroblasts is associated with the presence of both muscle progenitors in bone marrow and hematopoietic stem/progenitor cells in muscles, Stem Cells 21 (3), 363-371 (2003).
12. M. Kucia, K. Jankowski, R. Reca, M. Wysoczynski, L. Bandura, D.J. Allendorf, J. Zhang, J. Ratajczak, and M.Z. Ratajczak. CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion, J Mol Histol 35 (3), 233-245 (2004).
13. B. Moepps, M. Braun, K. Knopfle, K. Dillinger, W. Knochel, and P. Gierschik. Characterization of a Xenopus laevis CXC chemokine receptor 4: implications for hematopoietic cell development in the vertebrate embryo, Eur J Immunol 30 (10), 2924-2934 (2000).
14. Q. Ma, D. Jones, and T.A. Springer. The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment, Immunity 10 (4), 463-471 (1999).
15. A. Peled, I. Petit, O. Kollet, M. Magid, T. Ponomaryov, T. Byk, A. Nagler, H. Ben-Hur, A. Many, L. Shultz, O. Lider, R. Alon, D. Zipori, and T. Lapidot. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4, Science 283 (5403), 845-848 (1999).
16. S.M. Devine, N. Flomenberg, D.H. Vesole, J. Liesveld, D. Weisdorf, K. Badel, G. Calandra, and J.F. DiPersio. Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma, J Clin Oncol 22 (6), 1095-1102 (2004).
17. W.C. Liles, H.E. Broxmeyer, E. Rodger, B. Wood, K. Hubel, S. Cooper, G. Hangoc, G.J. Bridger, G.W. Henson, G. Calandra, and D.C. Dale. Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist, Blood 102 (8), 2728-2730 (2003).
18. I. Petit, M. Szyper-Kravitz, A. Nagler, M. Lahav, A. Peled, L. Habler, T. Ponomaryov, R. S. Taichman, F. Arenzana-Seisdedos, N. Fujii, J. Sandbank, D. Zipori, and T. Lapidot. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4, Nat Immunol 3 (7), 687-694 (2002).
19. M.Z. Ratajczak, R. Reca, M. Wysoczynski, M. Kucia, J.T. Baran, D.J. Allendorf, J. Ratajczak, and G.D. Ross. Transplantation studies in C3-deficient animals reveal a novel role of the third complement component (C3) in engraftment of bone marrow cells, Leukemia 18 (9), 1482-1490 (2004).
20. J. Ratajczak, R. Reca, M. Kucia, M. Majka, D.J. Allendorf, J.T. Baran, A. Janowska-Wieczorek, R.A. Wetsel, G.D. Ross, and M.Z. Ratajczak. Mobilization studies in mice deficient in either C3 or C3a receptor (C3aR) reveal a novel role for complement in retention of hematopoietic stem/progenitor cells in bone marrow, Blood 103 (6), 2071-2078 (2004).
21. R. Reca, D. Mastellos, M. Majka, L. Marquez, J. Ratajczak, S. Franchini, A. Glodek, M. Honczarenko, L.A. Spruce, A. Janowska-Wieczorek, J.D. Lambris, and M.Z. Ratajczak. Functional receptor for C3a anaphylatoxin is expressed by normal hematopoietic stem/progenitor cells, and C3a enhances their homing-related responses to SDF-1, Blood 101 (10), 3784-3793 (2003).
22. T. Schioppa, B. Uranchimeg, A. Saccani, S.K. Biswas, A. Doni, A. Rapisarda, S. Bernasconi, S. Saccani, M. Nebuloni, L. Vago, A. Mantovani, G. Melillo, and A. Sica. Regulation of the chemokine receptor CXCR4 by hypoxia, J Exp Med 198 (9), 1391-1402 (2003).
23. J. Libura, J. Drukala, M. Majka, O. Tomescu, J.M. Navenot, M. Kucia, L. Marquez, S.C. Peiper, F.G. Barr, A. Janowska-Wieczorek, and M.Z. Ratajczak. CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion, Blood 100 (7), 2597-2606 (2002).
24. K. Jankowski, M. Kucia, M. Wysoczynski, R. Reca, D. Zhao, E. Trzyna, J. Trent, S. Peiper, M. Zembala, J. Ratajczak, P. Houghton, A. Janowska-Wieczorek, and M.Z. Ratajczak. Both hepatocyte growth factor (HGF) and stromal-derived factor-1 regulate the metastatic behavior of human rhabdomyosarcoma cells, but only HGF enhances their resistance to radiochemotherapy, Cancer Res 63 (22), 7926-7935 (2003).
25. H. Nagase, M. Miyamasu, M. Yamaguchi, H. Kawasaki, K. Ohta, K. Yamamoto, Y. Morita, and K. Hirai. Glucocorticoids preferentially upregulate functional CXCR4 expression in eosinophils, J Allergy Clin Immunol 106 (6), 1132-1139 (2000).
26. K.H. Han, K.H. Hong, J. Ko, K. S. Rhee, M.K. Hong, J.J. Kim, Y.H. Kim, and S.J. Park. Lysophosphatidylcholine up-regulates CXCR4 chemokine receptor expression in human CD4 T cells, J Leukoc Biol 76 (1), 195-202 (2004).
27. S. Franitza, O. Kollet, A. Brill, G.G. Vaday, I. Petit, T. Lapidot, R. Alon, and O. Lider. TGF-beta1 enhances SDF-1alpha-induced chemotaxis and homing of naive T cells by up-regulating CXCR4 expression and downstream cytoskeletal effector molecules, Eur J Immunol 32 (1), 193-202 (2002).
28. R.E. Bachelder, M.A. Wendt, and A.M. Mercurio. Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4, Cancer Res 62 (24), 7203-7206 (2002).
29. Y. Shirazi and P.M. Pitha. Interferon downregulates CXCR4 (fusin) gene expression in peripheral blood mononuclear cells, J Hum Virol 1 (2), 69-76 (1998).
30. P. Jourdan, J.P. Vendrell, M.F. Huguet, M. Segondy, J. Bousquet, J. Pene, and H. Yssel. Cytokines and cell surface molecules independently induce CXCR4 expression on CD4+ CCR7+ human memory T cells, J Immunol 165 (2), 716-724 (2000).
31. K.W. Christopherson II, G. Hangoc, and H.E. Broxmeyer. Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/stromal cell-derived factor-1 alpha-mediated chemotaxis of human cord blood CD34+ progenitor cells, J Immunol 169 (12), 7000-7008 (2002).
32. A. Valenzuela-Fernandez, T. Planchenault, F. Baleux, I. Staropoli, K. Le-Barillec, D. Leduc, T. Delaunay, F. Lazarini, J.L. Virelizier, M. Chignard, D. Pidard, and F. Arenzana-Seisdedos. Leukocyte elastase negatively regulates Stromal cell-derived factor-1 (SDF-1)/CXCR4 binding and functions by amino-terminal processing of SDF-1 and CXCR4, J Biol Chem 277(18), 15677-15689 (2002).
33. J.P. Levesque, J. Hendy, Y. Takamatsu, B. Williams, I.G. Winkler, and P.J. Simmons. Mobilization by either cyclophosphamide or granulocyte colony-stimulating factor transforms the bone marrow into a highly proteolytic environment, Exp Hematol 30 (5), 440-449 (2002).
34. O. Kollet, A. Spiegel, A. Peled, I. Petit, T. Byk, R. Hershkoviz, E. Guetta, G. Barkai, A. Nagler, and T. Lapidot. Rapid and efficient homing of human CD34(+)CD38(-/low)CXCR4(+) stem and progenitor cells to the bone marrow and spleen of NOD/SCID and NOD/SCID/B2m(null) mice, Blood 97 (10), 3283-3291 (2001).
35. M. Berthebaud, C. Riviere, P. Jarrier, A. Foudi, Y. Zhang, D. Compagno, A. Galy, W. Vainchenker, and F. Louache. RGS16 is a negative regulator of SDF1-CXCR4 signaling in megakaryocytes, Blood (2005).
36. M. Wysoczynski, R. Reca, J. Ratajczak, M. Kucia, N. Shirvaikar, M. Honczarenko, M. Mills, J. Wanzeck, A. Janowska-Wieczorek, and M.Z. Ratajczak. Incorporation of CXCR4 into membrane lipid rafts primes homing-related responses of hematopoietic stem/progenitor cells to an SDF-1 gradient, Blood 105 (1), 40-48 (2005).
37. J. Raulin. Human immunodeficiency virus and host cell lipids. Interesting pathways in research for a new HIV therapy, Prog Lipid Res 41 (1), 27-65 (2002).
38. D.H. Nguyen and D. Taub. CXCR4 function requires membrane cholesterol: implications for HIV infection, J Immunol 168 (8), 4121-4126 (2002).
39. C. Gomez-Mouton, R.A. Lacalle, E. Mira, S. Jimenez-Baranda, D.F. Barber, A.C. Carrera, A.C. Martinez, and S. Manes. Dynamic redistribution of raft domains as an organizing platform for signaling during cell chemotaxis, J Cell Biol 164 (5), 759-768 (2004).
40. E.C. Lai. Lipid rafts make for slippery platforms, J Cell Biol 162 (3), 365-370 (2003).
41. J. L. Guan. Cell biology: integrins, rafts, Rac, and Rho, Science 303 (5659), 773-774 (2004).
42. C. Gomez-Mouton, J.L. Abad, E. Mira, R.A. Lacalle, E. Gallardo, S. Jimenez-Baranda, I. Illa, A. Bernad, S. Manes, and A.C. Martinez. Segregation of leading-edge and uropod components into specific lipid rafts during T cell polarization, Proc Natl Acad Sci USA 98 (17), 9642-9647 (2001).
43. Y. Gu, M.D. Filippi, J.A. Cancelas, J.E. Siefring, E.P. Williams, A.C. Jasti, C.E. Harris, A.W. Lee, R. Prabhakar, S.J. Atkinson, D.J. Kwiatkowski, and D.A. Williams. Hematopoietic cell regulation by Rac1 and Rac2 guanosine triphosphatases, Science 302 (5644), 445-449 (2003).
44. M.A. del Pozo, N.B. Alderson, W.B. Kiosses, H.H. Chiang, R.G. Anderson, and M.A. Schwartz. Integrins regulate Rac targeting by internalization of membrane domains, Science 303 (5659), 839-842 (2004).
45. M.J. Walport. Complement. First of two parts, N Engl J Med 344 (14), 1058-1066 (2001).
46. M.J. Walport. Complement: second of two parts, N Engl J Med 344 (15), 1140-1144 (2001).
47. G.D. Ross, J.D. Lambris, J.A. Cain, and S.L. Newman. Generation of three different fragments of bound C3 with purified factor I or serum, I: requirements for factor H vs CR1 cofactor activity, J Immunol 129 (5), 2051-2060 (1982).
48. J.E. Volanakis, M.M. Frank, and NetLibrary Inc., "The human complement system in health and disease," p. ix, 656. Marcel Dekker, New York, 1998.
49. D.R. Coombe, S.M. Watt, and C.R. Parish. Mac-1 (CD11b/CD18) and CD45 mediate the adhesion of hematopoietic progenitor cells to stromal cell elements via recognition of stromal heparan sulfate, Blood 84 (3), 739-752 (1994).
50. J. Teixido, M.E. Hemler, J.S. Greenberger, and P. Anklesaria. Role of beta 1 and beta 2 integrins in the adhesion of human CD34hi stem cells to bone marrow stroma, J Clin Invest 90 (2), 358-367 (1992).
51. Y. Xia, G. Borland, J. Huang, I.F. Mizukami, H.R. Petty, R.F. Todd III, and G.D. Ross. Function of the lectin domain of Mac-1/complement receptor type 3 (CD11b/CD18) in regulating neutrophil adhesion, J Immunol 169 (11), 6417-6426 (2002).
52. A. Ishida, H. Zeng, and M. Ogawa. Expression of lineage markers by CD34+ hematopoietic stem cells of adult mice, Exp Hematol 30 (4), 361-365 (2002).
53. A. Circolo, G. Garnier, W. Fukuda, X. Wang, T. Hidvegi, A.J. Szalai, D.E. Briles, J.E. Volanakis, R.A. Wetsel, and H.R. Colten. Genetic disruption of the murine complement C3 promoter region generates deficient mice with extrahepatic expression of C3 mRNA, Immunopharmacology 42 (1-3), 135-149 (1999).
54. S.S. Rao, S.O. Peters, R.B. Crittenden, F.M. Stewart, H.S. Ramshaw, and P.J. Quesenberry. Stem cell transplantation in the normal nonmyeloablated host: relationship between cell dose, schedule, and engraftment, Exp Hematol 25 (2), 114-121 (1997).
55. D. Kalant, S.A. Cain, M. Maslowska, A.D. Sniderman, K. Cianflone, and P.N. Monk. The chemoattractant receptor-like protein C5L2 binds the C3a des-Arg77/acylation-stimulating protein, J Biol Chem 278 (13), 11123-11129 (2003).
56. M. Honczarenko, B. Lu, A. Nicholson-Weller, N.P. Gerard, L.E. Silberstein, and C. Gerard. C5L2 receptor is not involved in C3a / C3a-desArg-mediated enhancement of bone marrow hematopoietic cell migration to CXCL12, Leukemia (2005).
57. M.Z. Ratajczak, R. Reca, and M. Wysoczynski. Reply to "C5L2 receptor is not involved in C3a/C3a-desArg-mediated enhancement of bone marrow hematopoietic cell migration to CXCL12" by Honczarenko et al, Leukemia (2005).
58. M.A. Moore, K. Hattori, B. Heissig, J.H. Shieh, S. Dias, R.G. Crystal, and S. Rafii. Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and angiopoietin-1, Ann NY Acad Sci 938 36-45; discussion 45-37 (2001).
59. J.P. Levesque, J. Hendy, Y. Takamatsu, P.J. Simmons, and L.J. Bendall. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide, J Clin Invest 111 (2), 187-196 (2003).
60. T. Papayannopoulou. Current mechanistic scenarios in hematopoietic stem/progenitor cell mobilization, Blood 103 (5), 1580-1585 (2004).
61. G.A. Velders, J.F. Pruijt, P. Verzaal, R. van Os, Y. van Kooyk, C.G. Figdor, E.J. de Kruijf, R. Willemze, and W.E. Fibbe. Enhancement of G-CSF-induced stem cell mobilization by antibodies against the beta 2 integrins LFA-1 and Mac-1, Blood 100 (1), 327-333 (2002).
62. K. Del Rio-Tsonis, P.A. Tsonis, I.K. Zarkadis, A.G. Tsagas, and J.D. Lambris. Expression of the third component of complement, C3, in regenerating limb blastema cells of urodeles, J Immunol 161 (12), 6819-6824 (1998).
63. M.M. Markiewski, D. Mastellos, R. Tudoran, R.A. DeAngelis, C.W. Strey, S. Franchini, R.A. Wetsel, A. Erdei, and J.D. Lambris. C3a and C3b activation products of the third component of complement (C3) are critical for normal liver recovery after toxic injury, J Immunol 173 (2), 747-754 (2004).
64. M. Kucia, J. Ratajczak, and M.Z. Ratajczak. Bone marrow as a source of circulating CXCR4+ tissue-committed stem cells, Biol Cell 97 (2), 133-146 (2005).
65. M. Kucia, B. Dawn, G. Hunt, Y. Guo, M. Wysoczynski, M. Majka, J. Ratajczak, F. Rezzoug, S.T. Ildstad, R. Bolli, and M.Z. Ratajczak. Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood after myocardial infarction, Circ Res 95 (12), 1191-1199 (2004).
66. M.Z. Ratajczak, M. Kucia, R. Reca, M. Majka, A. Janowska-Wieczorek, and J. Ratajczak. Stem cell plasticity revisited: CXCR4-positive cells expressing mRNA for early muscle, liver and neural cells 'hide out' in the bone marrow. Leukemia 18 (1), 29-40, 2004.